The redirection of healthcare and life sciences resources to COVID-19 has taken focus from other areas of need, including antimicrobial resistance.
Deepa Dahal
Advertisement
Articles by Deepa Dahal
Advertisement
Latest Updated Articles
COVID and AMR: Crisis Reframes Antibiotics FightPublished: December 11th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Ypsomed Announces New U.S.-Based Manufacturing Site in North Carolina
2
AstraZeneca to Announce Deal with Trump Administration: Report
3
Pharmaceutical Executive Daily: Most Favored Nation Order's Evolving Landscape
4
